![Understanding Next-Generation Immune Checkpoints and Deciphering Key Roles in the TME](https://d38uvx7mib76ry.cloudfront.net/public/images/RwQeHKlmtwwMMlGy4hbyfyCm9ONiZtwwMQ6Csi3n.png)
Summary:
In this podcast, you will hear a presentation from Dr Catherine Sabatos-Peyton, Novartis Institutes for Biomedical Research, from the 2021 Immuno-Oncology 360° Conference regarding TIM-3 as a myeloid cell target in cancer and potential targeting using MBG453.
To learn more about the Immuno-Oncology 360° Conference, please visit IO360Summit.com.
Related Podcasts
View All![Unlocking ctDNA's Potential for Prognostic Stratification, Tumor Evolution Insights & Accelerated Drug Development](https://d38uvx7mib76ry.cloudfront.net/public/images/B1auwoT8ay8rv3yuV4VCj1STzbGoy021dONMzRpa.png)
Unlocking ctDNA's Potential for Prognostic Stratification, Tumor Evolution Insights & Accelerated Drug Development
![Key Lessons from Manufacturing Cell-Based Immunotherapies to Accelerate Development and Process](https://d38uvx7mib76ry.cloudfront.net/public/images/AYpBueo73sCdV35PWH03VZAbzSTl5LAzpocI3Dw2.png)
Key Lessons from Manufacturing Cell-Based Immunotherapies to Accelerate Development and Process
![Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities](https://d38uvx7mib76ry.cloudfront.net/public/images/7vsSLL3HBWLTBtdS3MMK2xSWLQbAiFFpcrzUwzxk.png)
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
![Delivery Challenges from the Oncology Pipeline](https://d38uvx7mib76ry.cloudfront.net/public/images/KtKZ8eWZDTc3KHctMQwakc58erXkmiezGIWodFIR.png)